Oruka Therapeutics Inc. Common Stock vs SailPoint Inc. Common Stock — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.2 (market cap $5.18B), while SailPoint Inc. Common Stock trades at $19 (market cap $11.06B). The key difference: SailPoint Inc. Common Stock is far larger — about 2.1× Oruka Therapeutics Inc. Common Stock's market cap, and SailPoint Inc. Common Stock is trading nearer its 52-week high, Oruka Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and SailPoint Inc. Common Stock for 0 Days on average.
| ORKA | SAIL | |
|---|---|---|
Market Cap | $5.18B | $11.06B |
Volume | 490,798 | 3,269,663 |
Sector | Health | Technology |
52-Week High | $113.08 | $22.85 |
52-Week Low | $26.19 | $10.49 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $4.31B | $10.76B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →SailPoint, Inc. develops identity security software that helps enterprises manage and govern access to applications and data across users, machines, and AI agents. Its unified identity security platform combines automation and intelligence to control identity-related risk at scale for large organizations.
Read more on SAIL →